Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Predicting 15-year prostate cancer specific mortality after radical prostatectomy.
Eggener SE, Scardino PT, Walsh PC, Han M, Partin AW, Trock BJ, Feng Z, Wood DP, Eastham JA, Yossepowitch O, Rabah DM, Kattan MW, Yu C, Klein EA, Stephenson AJ.
J Urol. 2011 Mar;185(3):869-75. doi: 10.1016/j.juro.2010.10.057. Epub 2011 Jan 15.
Similar articles
Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program.
Ross AE, Loeb S, Landis P, Partin AW, Epstein JI, Kettermann A, Feng Z, Carter HB, Walsh PC.
J Clin Oncol. 2010 Jun 10;28(17):2810-6. doi: 10.1200/JCO.2009.25.7311. Epub 2010 May 3.
Complications of renal cryoablation: a single center experience.
Sidana A, Aggarwal P, Feng Z, Georgiades CS, Trock BJ, Rodriguez R.
J Urol. 2010 Jul;184(1):42-7. doi: 10.1016/j.juro.2010.03.013. Epub 2010 May 15.
Medical comorbidities associated with pediatric kidney stone disease.
Schaeffer AJ, Feng Z, Trock BJ, Mathews RI, Neu AM, Gearhart JP, Matlaga BR.
Urology. 2011 Jan;77(1):195-9. doi: 10.1016/j.urology.2010.06.062. Epub 2010 Oct 23.
Incidence and risk factors for inguinal and incisional hernia after laparoscopic radical prostatectomy.
Lin BM, Hyndman ME, Steele KE, Feng Z, Trock BJ, Schweitzer MA, Pavlovich CP.
Urology. 2011 Apr;77(4):957-62. doi: 10.1016/j.urology.2010.12.011. Epub 2011 Feb 18.
Active surveillance program for prostate cancer: an update of the Johns Hopkins experience.
Tosoian JJ, Trock BJ, Landis P, Feng Z, Epstein JI, Partin AW, Walsh PC, Carter HB.
J Clin Oncol. 2011 Jun 1;29(16):2185-90. doi: 10.1200/JCO.2010.32.8112. Epub 2011 Apr 4.
Treatment decision-making for localized prostate cancer: what younger men choose and why.
Sidana A, Hernandez DJ, Feng Z, Partin AW, Trock BJ, Saha S, Epstein JI.
Prostate. 2012 Jan;72(1):58-64. doi: 10.1002/pros.21406. Epub 2011 Apr 25.
Can we stop prostate specific antigen testing 10 years after radical prostatectomy?
Loeb S, Feng Z, Ross A, Trock BJ, Humphreys EB, Walsh PC.
J Urol. 2011 Aug;186(2):500-5. doi: 10.1016/j.juro.2011.03.116. Epub 2011 Jun 15.
The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up.
Antonarakis ES, Feng Z, Trock BJ, Humphreys EB, Carducci MA, Partin AW, Walsh PC, Eisenberger MA.
BJU Int. 2012 Jan;109(1):32-9. doi: 10.1111/j.1464-410X.2011.10422.x. Epub 2011 Jul 20.
Comparison of outcomes between pure laparoscopic vs robot-assisted laparoscopic radical prostatectomy: a study of comparative effectiveness based upon validated quality of life outcomes.
Willis DL, Gonzalgo ML, Brotzman M, Feng Z, Trock B, Su LM.
BJU Int. 2012 Mar;109(6):898-905. doi: 10.1111/j.1464-410X.2011.10551.x. Epub 2011 Sep 20.
Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancer.
Ross AE, Feng Z, Pierorazio PM, Landis P, Walsh PC, Carter HB, Trock BJ, Schaeffer EM.
BJU Int. 2012 Sep;110(5):651-7. doi: 10.1111/j.1464-410X.2011.10875.x. Epub 2012 Jan 30.
Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades.
Epstein JI, Feng Z, Trock BJ, Pierorazio PM.
Eur Urol. 2012 May;61(5):1019-24. doi: 10.1016/j.eururo.2012.01.050. Epub 2012 Feb 8.
Impact of surgical margin status on prostate-cancer-specific mortality.
Chalfin HJ, Dinizo M, Trock BJ, Feng Z, Partin AW, Walsh PC, Humphreys E, Han M.
BJU Int. 2012 Dec;110(11):1684-9. doi: 10.1111/j.1464-410X.2012.11371.x. Epub 2012 Jul 12.
Association of [-2]proPSA with biopsy reclassification during active surveillance for prostate cancer.
Tosoian JJ, Loeb S, Feng Z, Isharwal S, Landis P, Elliot DJ, Veltri R, Epstein JI, Partin AW, Carter HB, Trock B, Sokoll LJ.
J Urol. 2012 Oct;188(4):1131-6. doi: 10.1016/j.juro.2012.06.009. Epub 2012 Aug 15.
The impact of anatomical radical retropubic prostatectomy on cancer control: the 30-year anniversary.
Mullins JK, Feng Z, Trock BJ, Epstein JI, Walsh PC, Loeb S.
J Urol. 2012 Dec;188(6):2219-24. doi: 10.1016/j.juro.2012.08.028. Epub 2012 Oct 22.
Comparison of biochemical recurrence-free survival between periprostatic and pelvic lymph node metastases of prostate cancer.
González-Roibón N, Han JS, Lee S, Feng Z, Arslankoz S, Smith N, Pierorazio PM, Humphreys E, Deweese TL, Partin AW, Bivalacqua TJ, Han M, Trock B, Netto GJ.
Int J Surg Pathol. 2013 Aug;21(4):352-7. doi: 10.1177/1066896913482729. Epub 2013 Apr 5.
Multiphasic enhancement patterns of small renal masses (≤4 cm) on preoperative computed tomography: utility for distinguishing subtypes of renal cell carcinoma, angiomyolipoma, and oncocytoma.
Pierorazio PM, Hyams ES, Tsai S, Feng Z, Trock BJ, Mullins JK, Johnson PT, Fishman EK, Allaf ME.
Urology. 2013 Jun;81(6):1265-71. doi: 10.1016/j.urology.2012.12.049. Epub 2013 Apr 17.
Nightly vs on-demand sildenafil for penile rehabilitation after minimally invasive nerve-sparing radical prostatectomy: results of a randomized double-blind trial with placebo.
Pavlovich CP, Levinson AW, Su LM, Mettee LZ, Feng Z, Bivalacqua TJ, Trock BJ.
BJU Int. 2013 Oct;112(6):844-51. doi: 10.1111/bju.12253. Epub 2013 Aug 13.
Pathological and oncologic outcomes for men with positive lymph nodes at radical prostatectomy: The Johns Hopkins Hospital 30-year experience.
Pierorazio PM, Gorin MA, Ross AE, Feng Z, Trock BJ, Schaeffer EM, Han M, Epstein JI, Partin AW, Walsh PC, Bivalacqua TJ.
Prostate. 2013 Nov;73(15):1673-80. doi: 10.1002/pros.22702. Epub 2013 Sep 9.
Prostate specific antigen velocity risk count predicts biopsy reclassification for men with very low risk prostate cancer.
Patel HD, Feng Z, Landis P, Trock BJ, Epstein JI, Carter HB.
J Urol. 2014 Mar;191(3):629-37. doi: 10.1016/j.juro.2013.09.029. Epub 2013 Sep 20.
Filters: Manage Filters